The concentration of apoA-I (P = 0.045) was found to be reduced, while levels of S1P, SAA and TGs were found to be significantly increased (P < 0.001 for all) in T2DM patients compared to non-diabetic subjects (Table 1). The gene discussed is APOA1; the disease is type 2 diabetes mellitus.